Histoplasmosis

Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007 Oct 1;45(7):807-25.Full text  Abstract

Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021 Dec;21(12):e364-74. Abstract

National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and the Infectious Diseases Society of America. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: histoplasmosis. Sep 2019 [internet publication].Full text

Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Sep 1;200(5):535-50.Full text  Abstract

1. Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007 Oct 1;45(7):807-25.Full text  Abstract

2. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore). 1990 Nov;69(6):361-74. Abstract

3. Cano MV, Hajjeh RA. The epidemiology of histoplasmosis: a review. Semin Respir Infect. 2001 Jun;16(2):109-18. Abstract

4. Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021 Dec;21(12):e364-74. Abstract

5. Armstrong PA, Jackson BR, Haselow D, et al. Multistate epidemiology of histoplasmosis, United States, 2011-2014. Emerg Infect Dis. 2018 Mar;24(3):425-31.Full text  Abstract

6. Mazi PB, Sahrmann JM, Olsen MA, et al. The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern Era. Clin Infect Dis. 2022 Nov 11 [Epub ahead of print]. Abstract

7. Smith DJ, Williams SL, Endemic Mycoses State Partners Group, et al. Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis - United States, 2019. MMWR Surveill Summ. 2022 Aug 19;71(7):1-14.Full text  Abstract

8. Wheat LJ. Histoplasmosis: a review for clinicians from non-endemic areas. Mycoses. 2006 Jul;49(4):274-82. Abstract

9. Chamany S, Mirza S, Fleming JW, et al. A large histoplasmosis outbreak among high school students in Indiana, 2001. Pediatr Infect Dis J. 2004 Oct;23(10):909-14. Abstract

10. Assi MA, Sandid MS, Baddour LM, et al. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore). 2007 May;86(3):162-9. Abstract

11. Centers for Disease Control and Prevention. CDC Yellow Book 2024: travel associated infections and diseases. Section 5: Histoplasmosis. May 2023 [internet publication].Full text

12. Paya CV, Roberts GD, Cockerill FR 3rd. Transient fungemia in acute pulmonary histoplasmosis: detection by new blood-culturing techniques. J Infect Dis. 1987 Aug;156(2):313-5. Abstract

13. Woods JP, Heinecke EL, Luecke JW, et al. Pathogenesis of Histoplasma capsulatum. Semin Respir Infect. 2001 Jun;16(2):91-101. Abstract

14. Deepe GS Jr. Modulation of infection with Histoplasma capsulatum by inhibition of tumor necrosis factor-alpha activity. Clin Infect Dis. 2005 Aug 1;41(suppl 3):S204-7.Full text  Abstract

15. Jain VV, Evans T, Peterson MW. Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area. Respir Med. 2006 Jul;100(7):1291-3.Full text  Abstract

16. Mata-Essayag S, Colella MT, Rosello A, et al. Histoplasmosis: a study of 158 cases in Venezuela, 2000-2005. Medicine (Baltimore). 2008 Jul;87(4):193-202. Abstract

17. Sarosi GA, Johnson PC. Disseminated histoplasmosis in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992 Mar;14(suppl 1):S60-7. Abstract

18. Wallis RS, Broder M, Wong J, et al. Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis. 2005 Aug 1;41(suppl 3):S194-8.Full text  Abstract

19. Schwartz RS, Mackintosh FR, Schrier SL, et al. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer. 1984 Feb 1;53(3):411-9. Abstract

20. Assi M, Martin S, Wheat LJ, et al. Histoplasmosis after solid organ transplant. Clin Infect Dis. 2013 Dec;57(11):1542-9.Full text  Abstract

21. Kauffman CA, Freifeld AG, Andes DR, et al. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl Infect Dis. 2014 Apr;16(2):213-24.Full text  Abstract

22. Muhsen IN, Galeano S, Niederwieser D, et al. Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review. Lancet Haematol. 2023 Apr;10(4):e295-305. Abstract

23. McKinsey DS, Wheat LJ, Cloud GA, et al. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. Clin Infect Dis. 1999 May;28(5):1049-56.Full text  Abstract

24. Dismukes WE, Bradsher RW Jr, Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med. 1992 Nov;93(5):489-97. Abstract

25. National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and the Infectious Diseases Society of America. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: histoplasmosis. Sep 2019 [internet publication].Full text

26. Wheat LJ, Wass J, Norton J, et al. Cavitary histoplasmosis occurring during two large urban outbreaks. Analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore). 1984 Jul;63(4):201-9. Abstract

27. Wheat LJ, Conces D, Allen SD, et al. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin Respir Crit Care Med. 2004 Apr;25(2):129-44. Abstract

28. Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Sep 1;200(5):535-50.Full text  Abstract

29. Wheat LJ. Improvements in diagnosis of histoplasmosis. Expert Opin Biol Ther. 2006 Nov;6(11):1207-21. Abstract

30. Wheat LJ, Garringer T, Brizendine E, et al. Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. Diagn Microbiol Infect Dis. 2002 May;43(1):29-37. Abstract

31. Wheat LJ, Connolly-Stringfield P, Williams B, et al. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. Am Rev Respir Dis. 1992 Jun;145(6):1421-4. Abstract

32. World Health Organization. Guidelines for diagnosing and managing disseminated histoplasmosis among people living with HIV. 1 April 2020 [internet publication].Full text

33. Smith DJ, Free RJ, Thompson Iii GR, et al. Clinical testing guidance for coccidioidomycosis, histoplasmosis, and blastomycosis in patients with community-acquired pneumonia for primary and urgent care providers. Clin Infect Dis. 2023 Oct 6:ciad619.Full text  Abstract

34. Centers for Disease Control and Prevention. Fungal diseases: ​clinical testing guidance for coccidioidomycosis, histoplasmosis, and blastomycosis in patients with community-acquired pneumonia. Nov 2023 [internet publication].Full text

35. Williams B, Fojtasek M, Connolly-Stringfield P, et al. Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind. Arch Pathol Lab Med. 1994 Dec;118(12):1205-8. Abstract

36. Fandiño-Devia E, Rodríguez-Echeverri C, Cardona-Arias J, et al. Antigen detection in the diagnosis of histoplasmosis: a meta-analysis of diagnostic performance. Mycopathologia. 2016 Apr;181(3-4):197-205. Abstract

37. Hage CA, Davis TE, Egan L, et al. Diagnosis of pulmonary histoplasmosis and blastomycosis by detection of antigen in bronchoalveolar lavage fluid using an improved second-generation enzyme-linked immunoassay. Respir Med. 2007 Jan;101(1):43-7.Full text  Abstract

38. Fojtasek MF, Kleiman MB, Connolly-Stringfield P, et al. The Histoplasma capsulatum antigen assay in disseminated histoplasmosis in children. Pediatr Infect Dis J. 1994 Sep;13(9):801-5. Abstract

39. Wheat J, French ML, Kohler RB, et al. The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak. Ann Intern Med. 1982 Nov;97(5):680-5. Abstract

40. Guimarães AJ, Nosanchuk JD, Zancopé-Oliveira RM. Diagnosis of histoplasmosis. Braz J Microbiol. 2006 Jan;37(1):1-13.Full text  Abstract

41. Richer SM, Smedema ML, Durkin MM, et al. Improved diagnosis of acute pulmonary histoplasmosis by combining antigen and antibody detection. Clin Infect Dis. 2016 Apr 1;62(7):896-902.Full text  Abstract

42. Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011 Sep;53(5):448-54.Full text  Abstract

43. Odio CM, Navarrete M, Carrillo JM, et al. Disseminated histoplasmosis in infants. Pediatr Infect Dis J. 1999 Dec;18(12):1065-8. Abstract

44. Leggiadro RJ, Barrett FF, Hughes WT. Disseminated histoplasmosis of infancy. Pediatr Infect Dis J. 1988 Nov;7(11):799-805. Abstract

45. Nadrous HF, Antonios VS, Terrell CL, et al. Pulmonary cryptococcosis in nonimmunocompromised patients. 2003 Dec;124(6):2143-7. Abstract

46. Stevens DA. Coccidioidomycosis. N Engl J Med. 1995 Apr 20;332(16):1077-82. Abstract

47. Cano MV, Ponce-de-Leon GF, Tippen S, et al. Blastomycosis in Missouri: epidemiology and risk factors for endemic disease. Epidemiol Infect. 2003 Oct;131(2):907-14.Full text  Abstract

48. Adderson EE. Histoplasmosis in a pediatric oncology center. J Pediatr. 2004 Jan;144(1):100-6. Abstract

49. Murray M, Hine P. Treating progressive disseminated histoplasmosis in people living with HIV. Cochrane Database Syst Rev. 2020 Apr 28;(4):CD013594.Full text  Abstract

50. Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis. 2004 May 15;38(10):1485-9.Full text  Abstract

51. Myint T, Anderson AM, Sanchez A, et al. Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapse. Medicine (Baltimore). 2014 Jan;93(1):11-8.Full text  Abstract

52. Massachusetts General Hospital. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-1991. A 48-year-old man with dysphagia, chest pain, fever, and a subcarinal mass. N Engl J Med. 1991 Apr 11;324(15):1049-56. Abstract

53. Limper AH, Knox KS, Sarosi GA, et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan 1;183(1):96-128.Full text  Abstract

54. Goodwin RA, Loyd JE, Des Prez RM. Histoplasmosis in normal hosts. Medicine (Baltimore). 1981 Jul;60(4):231-66. Abstract

55. Young EJ, Vainrub B, Musher DM. Pericarditis due to histoplasmosis. JAMA. 1978 Oct 13;240(16):1750-1. Abstract

56. Rosenthal J, Brandt KD, Wheat LJ, et al. Rheumatologic manifestations of histoplasmosis in the recent Indianapolis epidemic. Arthritis Rheum. 1983 Sep;26(9):1065-70. Abstract

57. Medeiros AA, Marty SD, Tosh FE, et al. Erythema nodosum and erythema multiforme as clinical manifestations of histoplasmosis in a community outbreak. N Engl J Med. 1966 Feb 24;274(8):415-20. Abstract

58. Wheat LJ, Batteiger BE, Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore). 1990 Jul;69(4):244-60. Abstract

59. Whitt SP, Koch GA, Fender B, et al. Histoplasmosis in pregnancy: case series and report of transplacental transmission. Arch Intern Med. 2004 Feb 23;164(4):454-8. Abstract

60. Moudgal VV, Sobel JD. Antifungal drugs in pregnancy: a review. Expert Opin Drug Saf. 2003 Sep;2(5):475-83. Abstract

61. Mocherla S, Wheat LJ. Treatment of histoplasmosis. Semin Respir Infect. 2001 Jun;16(2):141-8. Abstract

62. Seyedmousavi S, Verweij PE, Mouton JW. Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases. Expert Rev Anti Infect Ther. 2015 Jan;13(1):9-27. Abstract

63. Kataria YP, Campbell PB, Burlingham BT. Acute pulmonary histoplasmosis presenting as adult respiratory distress syndrome: effect of therapy on clinical and laboratory features. South Med J. 1981 May;74(5):534-7;542. Abstract